AcelRX Pharmaceuticals recently submitted a new drug application to the U.S. Food and Drug Administration for ARX-04. Read More »

CVS Health recently launched Transform Diabetes Care, a program dedicated to helping clients improve member health outcomes. Read More »

Marrk Merritt, president and CEO of the Pharmaceutical Care Management Association, writes, "The truth is PBMs reduce costs for payers and consumers by 30 percent or more and are part of the solution. It’s time for drug manufacturers to take responsibility for their own business mistakes instead of blaming others." Read More »

Endo International, PLC, a subsidiary of Par Pharmaceutical, recently released mycophenolate mofetil hydrochloride (HCI) in the U.S. following Food and Drug Administration approval of its Abbreviated New Drug Application. Read More »

The Centers for Disease Control and Prevention has awarded $184 million in funding to various groups in an effort to protect Americans from Zika virus infection. Read More »

Medinol, a global Interventional Cardiology device company, recently announced positive twelve-month clinical results from its BIONICS study. The study was conducted to analyze and evaluate EluNIR, the company’s coronary stent system and the first ever elastomer-coated drug eluting stent (eDES). Read More »

The American Journal of Health-System Pharmacy has applauded the 21st Century Cures Act was signed into law by President Barack Obama on Dec. 13. Read More »

Teva Pharmaceuticals Industries Ltd. (Teva) recently announced a settlement with the United States government related to allegations of violating the Foreign Corrupt Practices Act (FCPA) in Ukraine, Mexico and Russia. Read More »

Direct Relief recently announced that it airlifted 82 tons of medical aid to Haiti for the treatment of cholera and other diseases that have become rampant since Hurricane Matthew in October. Read More »

Aurinia Pharmaceuticals Inc., a clinical stage biopharmaceutical company focused on the global immunology market, recently partnered with Lonza for the manufacture of voclosporin active pharmaceutical ingredient (API). Read More »

Genentech, a member of the Roche Group, recently announced that the primary endpoint for the Phase III HAVEN 1 study has been met. The study evaluates emicizumab prophylaxis in people 12 years of age or older with hemophilia A and inhibitors to factor VIII. Read More »

The Express Scripts Holding Company recently revealed plans to present at the J.P. Morgan Healthcare Conference next week in San Francisco. Read More »

Bayer recently announced an agreement with Leica Biosystems to collaborate on developing companion diagnostic tests based on tissue samples for cancer patients. Read More »

Pernix Therapeutics Holdings Inc., a pharmaceutical company specializing in pain and central nervous system conditions, recently appointed Gabriel Leung to its board of directors. Read More »

Medical technology company Zynex updated its November orders, fourth-quarter estimate and a loan forbearance agreement. Read More »

Veloxis Pharmaceuticals will establish a warrant program for its board members and its employees with the Veloxis Board of Directors exercising, in part, an authorization pursuant to the Articles of Association. Read More »

Avella has moved its operations to a new 50,000-square-foot corporate headquarters in Phoenix. Read More »

The biotech company Rebiotix Inc. recently announced that a patient has been treated for the first time with a capsule that delivers live microbes into the human intestinal tract. Read More »

AcelRx Pharmaceuticals presented results from its Phase 3 SAP303 study of ARX-04 at the 15th Annual Pain Medicine Meeting of the American Society of Regional Anesthesia and Pain Medicine. Read More »

AzurRx BioPharma has partnered with Mayoly Spindler to begin a Phase II clinical trial to assess the safety and effectiveness of MS1819-SD for the treatment of patients who have exocrine pancreatic insufficiency that is the result of chronic pancreatitis. Read More »